The use of (costly) growth hormone (GH) treatment in short children is often justified by the assumption that short stature considerably reduces quality of life in adults. We tested this assumption in 5 groups of short adults: 25 patients with isolated GH deficiency; 17 male patients with childhood onset renal failure; 25 women with Turner syndrome and 26 patients who were presented as a child to a paediatrician for idiopathic short stature. A group of 44 short individuals with presumably idiopathic short stature, who had not been presented to a paediatrician for short stature, was sampled from the general population (‘normal shorts’). We measured quality of life in terms of socio-economic variables, the Nottingham Health Profile and time trade-off. The mean height of most groups was close to the 3rd percentile. The chance of having a partner was low for all groups, except for the normal shorts. Problems with job application were only reported in Turner syndrome. The scores on the Nottingham Health Profile were all within the normal range, but GH-deficient adults had a higher score on the domain energy than normal shorts. Women with Turner syndrome, individuals with renal failure, and those with idiopathic short stature had a wish to be taller, with an estimated reduction in quality of life of 2–4% (time trade-off). As the normal shorts did not show any sign of a reduced quality of life, we falsify the assumption of a direct relation between short stature and quality of life. The complaints of patients with idiopathic short stature around the 3rd percentile seem to be the result of unsuccessful coping strategies.

1.
Sandberg DE, Brook AE, Campos SP: Short stature: A psychosocial burden requiring growth hormone therapy? Pediatrics 1994;94:832–840.
2.
Rosenbloom AL: Height screening in the community: The commercialization of growth. Clin Paediatr 1990;29:288–292.
3.
Lantos J, Siegler M, Cuttler L: Ethical issues in growth hormone therapy. JAMA 1989;461:1020–1024.
4.
Stabler B, Clopper RR, Siegel PT, et al: Academic achievement and psychological adjustment in short children. J Dev Behav Pediatr 1994;15:1–6.
5.
Sartorio A, Morabito F, Peri G, et al: The social outcome of adults with constitutional growth delay. J Endocrinol Invest 1990;13:593–595.
6.
Holl RW, Schröder H, Heinze E: Are short boys disadvantaged as adults? A re-evaluation of 77 men with constitutional growth delay and (or) familial short stature. Dtsch Med Wochenschr 1991;116:928–934.
7.
Voss LD, Bailey BJR, Mulligan TJ, et al: Short stature and school performance. The Wessex Growth Study. Acta Paediatr Scand 1991;377(suppl):29–31.
8.
Voss L, Mulligan J: The short ‘normal’ child in school: Self-esteem, behavior, and attainment before puberty (The Wessex Growth Study); in Stabler B; Underwood LE (eds): Growth, Stature and Adaption. University of North Carolina at Chapel Hill, Office of Continuing Medical Information, 1994.
9.
Vance M, Ingersoll GM, Golden MP: Short stature in a nonclinical sample: Not a big problem; in Stabler B, Underwood LE (eds): Growth, Stature and Adaption. University of North Carolina at Chapel Hill, Office of Continuing Medical Information, 1994, pp 35–45.
10.
Roede MJ, Van Wieringen JC: Growth diagrams 1980. Netherlands third national survey. Tijdschr Soc Gezondheidszorg 1985;63 (suppl):1–34.
11.
Rikken B, Busschbach J, Cessie SL, et al: Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature. Clin Endocrinol 1995;43:205–211.
12.
Hoes AW, Grobbee DE, Valkenburg HA, et al: Cardiovascular risk and all-cause mortality: A 12-years follow-up study in the Netherlands. Eur J Epidemiol 1993;9:285–292.
13.
Valkenburg HA, Hofman A, Klein F, et al: An epidemiological study of cardiovascular risk indicators. Ned Tijdschr Geneeskd 1980;124:183–189.
14.
Essink-Bot ML, Royen L van, Krabbe P, Bonsel GJ, Rutten FFH: The impact of migraine on health status. Headache 1995;35:200–206.
15.
Björk S, Jönssen J, Westphal O, et al: Quality of life of adults with growth hormone deficiency: A controlled study. Acta Paediatr Scand 1989;356(suppl):55–59.
16.
Rosén T, Wirén L, Wilhelmsen L, et al: Decreased psychological well-being in adult patient with growth hormone deficiency. Clin Endocrinol 1994;40:111–116.
17.
Mårdh G, Lundin K, Borg G, et al: Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: Combined data from 12 European placebo-controlled clinical trials. Endocrinol Metab 1994;1(suppl A):43–49.
18.
Torrance GW: Measurement of health state utilities for economic appraisal. J Health Econ 1986;5:1–30.
19.
Froberg DG, Kane RL: Methodology for measuring health-state preferences. II: Scaling methods. J Clin Epidemiol 1989;42:459–471.
20.
McKenna SP, Doward LC: Quality of life assessment of adults with growth hormone deficiency. Pharmacoeconomics 1994;6:434–441.
21.
De Boer H, Blok GJ, Van Der Veen EA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63–86.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.